H. Griph

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Jianying Zhou, Erdem Goker, Jun Zhao, 2019, The Lancet.

Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis

A. Carneiro, H. Griph, J. Marsal, 2017, Cancer Immunology, Immunotherapy.

Bronchoscopic diagnosis of pulmonary infections in a heterogeneous, nonselected group of patients.

H. Miörner, L. Eriksson, K. Ekdahl, 1993, Chest.

Clinical Utility of Targeted Sequencing in Lung Cancer: Experience From an Autonomous Swedish Health Care Center

Å. Borg, G. Jönsson, J. Staaf, 2020, JTO clinical and research reports.